TXNRD1 and astrocytoma (excluding glioblastoma): An analysis of 433 astrocytomas has indicated that thioredoxin reductase 1 (TrxR1) becomes up-regulated in more than 66% cases, which is significantly associated with higher proliferation activity and worse prognosis2.